Personalized Cancer Vaccine Company Raises $93 Million
Venture funds seeded by drug giant Eli Lilly and search behemoth Alphabet are giving $92.7 million to a startup that aims to use machine learning to create personalized treatments for lung and stomach cancer.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NYSE:LLY NASDAQ:GOOG Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Gastric (Stomach) Cancer | Learning | Pharmaceuticals | Universities & Medical Training | Vaccines